Agid Y - Search Results

1

Are dopaminergic neurons selectively vulnerable to Parkinson's disease?

Agid Y, Ruberg M, Javoy-Agid F, Hirsch E, Raisman-Vozari R, Vyas S, Faucheux B, Michel P, Kastner A, Blanchard V, et al. Agid Y, et al. Adv Neurol. 1993;60:148-64. Adv Neurol. 1993. PMID: 8420132 Review. No abstract available.

2

The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?

Agid Y, Graybiel AM, Ruberg M, Hirsch E, Blin J, Dubois B, Javoy-Agid F. Agid Y, et al. Adv Neurol. 1990;53:83-100. Adv Neurol. 1990. PMID: 1978522 Review. No abstract available.

3

Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

Hirsch EC, Duyckaerts C, Javoy-Agid F, Hauw JJ, Agid Y. Hirsch EC, et al. Among authors: agid y. Ann Neurol. 1990 Jun;27(6):676-82. doi: 10.1002/ana.410270615. Ann Neurol. 1990. PMID: 2360804

4

Biochemistry of Parkinson's disease 28 years later: a critical review.

Agid Y, Cervera P, Hirsch E, Javoy-Agid F, Lehericy S, Raisman R, Ruberg M. Agid Y, et al. Mov Disord. 1989;4 Suppl 1:S126-44. doi: 10.1002/mds.870040514. Mov Disord. 1989. PMID: 2566912 Review. No abstract available.

5

Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?

Mouatt-Prigent A, Agid Y, Hirsch EC. Mouatt-Prigent A, et al. Among authors: agid y. Brain Res. 1994 Dec 30;668(1-2):62-70. doi: 10.1016/0006-8993(94)90511-8. Brain Res. 1994. PMID: 7704619

6

Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.

Levy R, Ruberg M, Herrero MT, Villares J, Javoy-Agid F, Agid Y, Hirsch EC. Levy R, et al. Among authors: agid y. Neurology. 1995 Jan;45(1):127-34. doi: 10.1212/wnl.45.1.127. Neurology. 1995. PMID: 7824102

7

Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.

Anglade P, Tsuji S, Javoy-Agid F, Agid Y, Hirsch EC. Anglade P, et al. Among authors: agid y. Ann Neurol. 1995 Feb;37(2):265-72. doi: 10.1002/ana.410370219. Ann Neurol. 1995. PMID: 7847868

8

Dopamine denervation, age of onset, and Parkinson's disease.

Ruberg M, Scherman D, Javoy-Agid F, Agid Y. Ruberg M, et al. Among authors: agid y. Neurology. 1995 Feb;45(2):392. doi: 10.1212/wnl.45.2.392. Neurology. 1995. PMID: 7854549 No abstract available.

9

Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.

Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, Agid Y. Kastner A, et al. Among authors: agid y. Ann Neurol. 1994 Aug;36(2):206-14. doi: 10.1002/ana.410360213. Ann Neurol. 1994. PMID: 7914399

10

Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.

Kastner A, Hirsch EC, Agid Y, Javoy-Agid F. Kastner A, et al. Among authors: agid y. Brain Res. 1993 Mar 26;606(2):341-5. doi: 10.1016/0006-8993(93)91005-d. Brain Res. 1993. PMID: 8098254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters